Sustained low-dose treatment with the histone deacetylase inhibitor LBH589 induces terminal differentation of osteosarcoma cells

Autoria(s): Cain, Jason E.; McCaw, Andrew; Jayasekara, W. Samantha N.; Rossello, Fernando J.; Marini, Kieren D.; Irving, Aaron T.; Kansara, Maya; Thomas, David M.; Ashley, David M.; Watkins, D. Neil
Data(s)

01/01/2013
Identificador

http://hdl.handle.net/10536/DRO/DU:30054649
Idioma(s)

eng
Publicador

Hindawi Publishing Corporation
Relação

http://dro.deakin.edu.au/eserv/DU:30054649/ashley-sustainedlowdosetreatment-2013.pdf

http://dx.doi.org/10.1155/2013/608964
Palavras-Chave #cancer #osteosarcoma #HDACi therapy #Panobinostat #LBH589 #terminal differentiation
Tipo

Journal Article
Acesso ao item digital